Form 8-K - Current report:
SEC Accession No. 0001213900-24-095002
Filing Date
2024-11-06
Accepted
2024-11-06 16:21:00
Documents
17
Period of Report
2024-10-31
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0220145-8k_renalytix.htm   iXBRL 8-K 43512
2 PRESS RELEASE ea022014501ex99-1_renalytix.htm EX-99.1 12020
3 PRESS RELEASE ea022014501ex99-2_renalytix.htm EX-99.2 6271
4 GRAPHIC ex99-1_001.jpg GRAPHIC 3781
5 GRAPHIC ex99-2_001.jpg GRAPHIC 3781
  Complete submission text file 0001213900-24-095002.txt   250511

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE rnlx-20241031.xsd EX-101.SCH 3033
7 XBRL LABEL FILE rnlx-20241031_lab.xml EX-101.LAB 34240
8 XBRL PRESENTATION FILE rnlx-20241031_pre.xml EX-101.PRE 22371
19 EXTRACTED XBRL INSTANCE DOCUMENT ea0220145-8k_renalytix_htm.xml XML 3405
Mailing Address FINSGATE 5-7 CRANWOOD STREET LONDON X0 EC1V 9EE
Business Address FINSGATE 5-7 CRANWOOD STREET LONDON X0 EC1V 9EE 44 29 2071 0570
Renalytix plc (Filer) CIK: 0001811115 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-39387 | Film No.: 241431347
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)